Overview

A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The study will examine midazolam pharmacokinetics following single dose administration of 3 planned dose levels of GGF2 .
Phase:
Phase 1
Details
Lead Sponsor:
Acorda Therapeutics
Treatments:
Midazolam